Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?

Franceschi F, Di Simone N, D'Ippolito S, Castellani R, Di Nicuolo F, Gasbarrini G, Yamaoka Y, Todros T, Scambia G, Gasbarrini A.

Helicobacter. 2012 Dec;17(6):426-34. doi: 10.1111/j.1523-5378.2012.00966.x. Epub 2012 Jun 29.

2.

[Production of a recombinant CagA protein for the detection of Helicobacter pylori CagA antibodies].

Akgüç M, Karatayli E, Çelik E, Koyuncu D, Çelik İ, Karatayli SC, Özden A, Bozdayi AM.

Mikrobiyol Bul. 2014 Jul;48(3):402-12. Turkish.

3.

Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis.

Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Genta RM.

Circulation. 2002 Jul 23;106(4):430-4.

PMID:
12135941
4.

Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women?

Chen Q, Viall C, Kang Y, Liu B, Stone P, Chamley L.

Placenta. 2009 Sep;30(9):767-73. doi: 10.1016/j.placenta.2009.06.008. Epub 2009 Jul 23.

PMID:
19631379
5.
7.

[Helicobacter pylori CagA antigen antibodies].

Havlasová J, Bures J, Rejchrt S, Voxová B, Krejsek J.

Cas Lek Cesk. 1998 Jun 29;137(13):404-9. Czech.

PMID:
9748734
8.

Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.

Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T.

Am J Gastroenterol. 2005 Jun;100(6):1265-70.

PMID:
15929755
9.

Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?

Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O.

Helicobacter. 2004 Jun;9(3):271-7.

PMID:
15165264
10.

A novel diagnostic monoclonal antibody specific for Helicobacter pylori CagA of East Asian type.

Yasuda A, Uchida T, Nguyen LT, Kawazato H, Tanigawa M, Murakami K, Kishida T, Fujioka T, Moriyama M.

APMIS. 2009 Dec;117(12):893-9. doi: 10.1111/j.1600-0463.2009.02548.x.

PMID:
20078554
11.

[Helicobacter pylori genotypes and their association with host's immune response].

Garza-González E, Pérez-Pérez GI, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ.

Rev Gastroenterol Mex. 2002 Jul-Sep;67(3):155-60. Spanish.

PMID:
12653051
12.

Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis.

Bonvicini F, Baldini L, Pretolani S, Figura N, Epifanio G, Armuzzi A, Miglio F, Gasbarrini G.

Ital J Gastroenterol Hepatol. 1997 Oct;29(5):409-14.

PMID:
9494848
13.

Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.

Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune Ki, Kawabe T, Shiratori Y, Omata M.

Cancer. 2000 Apr 1;88(7):1530-5.

PMID:
10738209
14.

IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.

de la Cruz-Herrera CF, Flores-Luna L, Gutierrez-Xicotencatl L, Chihu-Amparan L, Sánchez-Aleman MA, Lazcano-Ponce E, Torres J, Ayala G.

J Med Microbiol. 2013 Apr;62(Pt 4):591-8. doi: 10.1099/jmm.0.050567-0. Epub 2013 Jan 3.

PMID:
23288428
15.

The association of interleukin-18 promoter polymorphisms and serum levels with duodenal ulcer, and their correlations with bacterial CagA and VacA virulence factors.

Rezaeifar A, Eskandari-Nasab E, Moghadampour M, Kharazi-Nejad E, Hasani SS, Asadi-Saghandi A, Hadadi-Fishani M, Sepanjnia A, Sadeghi-Kalani B.

Scand J Infect Dis. 2013 Aug;45(8):584-92. doi: 10.3109/00365548.2013.794301. Epub 2013 Jun 9.

PMID:
23746337
16.

Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide.

Figura N, Palazzuoli A, Vaira D, Campagna M, Moretti E, Iacoponi F, Giordano N, Clemente S, Nuti R, Ponzetto A.

J Clin Pathol. 2014 Mar;67(3):251-7. doi: 10.1136/jclinpath-2013-201743. Epub 2013 Dec 13.

17.

[Development of panel of monoclonal antibodies for detection of CagA cytotoxin of Helicobacter pylori].

Klimovich AV, Griazeva IV, Samoĭlovich MP, Terekhina LA, Krutetskaia IIu, Klimovich VB.

Zh Mikrobiol Epidemiol Immunobiol. 2010 May-Jun;(3):62-7. Russian.

PMID:
20734721
18.

Differential nuclear expression of enhancer A DNA-binding proteins in human first trimester trophoblast cells.

Boucraut J, Hawley S, Robertson K, Bernard D, Loke YW, Le Bouteiller P.

J Immunol. 1993 May 1;150(9):3882-94.

PMID:
8473737
19.

Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.

Ilie M, Dascălu L, Chifiriuc C, Popa M, Constantinescu G, Tănăsescu C, Baltac A.

Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):101-4.

PMID:
22570922
20.

The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.

Figura N, Di Cairano G, Lorè F, Guarino E, Gragnoli A, Cataldo D, Giannace R, Vaira D, Bianciardi L, Kristodhullu S, Lenzi C, Torricelli V, Orlandini G, Gennari C.

J Physiol Pharmacol. 1999 Dec;50(5):817-26.

PMID:
10695561

Supplemental Content

Support Center